Acyltransferases
The class of acylgroup transferring enzymes includes a multitude of substrate specific enzymes. For example, diacylglycerol O-acyltransferase 1 (DGAT1; EC 2.3.1.20) catalyzes the final step of the synthesis of triglycerides (TG) and plays a critical role in dietary fat absorption in the small intestine. Therefore, it is a potential therapeutic target for treatment of obesity and related metabolic diseases[1]. The co-enzyme Acyl-CoA is the donor substrate of the acetyl group that is transferred to the diglyceride substrates of DGAT1.
[1] Y. Hiramine, T. Tanabe. Characterization of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) enzyme of human small intestine. J. Physiol. Biochem. 2011, 67, 259-264.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2059 | A 922500 | Highly potent and selective diacylglycerol acyltransferase 1 (DGAT-1) inhibitor | €105.00 | |
1490 | Anacardic acid A | HAT inhibitor | €60.00 | |
2960 | ATR-101 | Potent, selective, and orally active ACAT1 inhibitor | €145.00 | |
2042 | Azithromycin | Macrolide antibiotic; Binds the 50S ribosomal subunit | €50.00 | |
2506 | BMS 303141 | Cell-permeable ATP-citrate lyase (ACL) inhibitor | €90.00 | |
1781 | C 646 | HAT inhibitor (p300/CBP selective) | €60.00 | |
2063 | Clindamycin | Inhibitor of peptidyl transferase; Antibiotic | €75.00 | |
2765 | CPTH2 | HAT inhibitor (Gcn5p specific) | €125.00 | |
2568 | EML 425 | Potent reversible dual inhibitor of CBP and p300 (HAT/KAT3) | €95.00 | |
2208 | Gallic acid | Multi-affinity drug. Antioxidant. | €50.00 | |
2212 | IWP L6 | Highly potent porcupine (Porcn) inhibitor | €125.00 | |
2510 | IWR-1-endo | Inhibitor of the Wnt/β-catenin pathway strongly inhibiting TNKS1 and TNKS2 | €85.00 | |
2319 | L 002 | Inhibitor of p300 HAT (KAT3B) and p53 acetylation | €80.00 | |
2048 | Linezolid | Protein synthesis inhibitor; antibiotic | €80.00 | |
1785 | MG 149 | HAT inhibitor (Tip60 and MOZ specific) | €90.00 |